Company Search:
Advanced Search
Sponsored Links
Adma Biologics Inc Company Snapshot
Adma Biologics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adma Biologics Inc with three other companies in this sector in the United States: Champions Oncology Inc (2016 sales of $11.18 million ), Aviragen Therapeutics Inc ($9.30 million of which 100% was Antibody Products), and Protalix Biotherapeutics Inc ($9.20 million of which 100% was Biotherapeutic Products).

Sales Analysis. Adma Biologics Inc reported sales of $10.66 million for the year ending December of 2016. This represents an increase of 48.5% versus 2015, when the company's sales were $7.18 million. Sales at Adma Biologics Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 1,301%). Sales of Plasma Collection Center saw an increase of 49.2% in 2016, from $7.05 million to $10.52 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adma Biologics Inc
  Stock Performance Chart for Adma Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 4.82
(Figures in U.S. Dollars)
1 Week -2.2%   13 Weeks 1.5%  
4 Weeks 7.1%   52 Weeks -33.9%  
Adma Biologics Inc Key Data:
  Ticker: ADMA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 10,661,037
(Year Ending Jan 2017).
Employees: 92
  Currency: U.S. Dollars Market Cap: 62,114,092
  Fiscal Yr Ends: December Shares Outstanding: 12,886,741
  Share Type: Common Closely Held Shares: 1,499,400
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.